Annual Total Liabilities
$24.45 M
-$1.16 M-4.52%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual total liabilities is $24.45 million, with the most recent change of -$1.16 million (-4.52%) on December 31, 2023.
- During the last 3 years, CUE annual total liabilities has risen by +$3.82 million (+18.54%).
- CUE annual total liabilities is now -4.52% below its all-time high of $25.60 million, reached on December 31, 2022.
Performance
CUE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$19.44 M
-$1.26 M-6.10%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly total liabilities is $19.44 million, with the most recent change of -$1.26 million (-6.10%) on September 30, 2024.
- Over the past year, CUE quarterly total liabilities has dropped by -$1.26 million (-6.10%).
- CUE quarterly total liabilities is now -28.41% below its all-time high of $27.16 million, reached on June 30, 2023.
Performance
CUE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CUE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.5% | -6.1% |
| 3 y3 years | +18.5% | -24.1% |
| 5 y5 years | +114.6% | -24.1% |
CUE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.5% | +36.5% | -28.4% | +8.6% |
| 5 y | 5-year | -4.5% | +43.6% | -28.4% | +26.6% |
| alltime | all time | -4.5% | +6396.1% | -28.4% | +1661.2% |
Cue Biopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.44 M(-6.1%) |
| Jun 2024 | - | $20.71 M(-13.4%) |
| Mar 2024 | - | $23.91 M(-2.2%) |
| Dec 2023 | $24.45 M(-4.5%) | $24.45 M(-6.8%) |
| Sep 2023 | - | $26.22 M(-3.5%) |
| Jun 2023 | - | $27.16 M(+1.9%) |
| Mar 2023 | - | $26.66 M(+4.2%) |
| Dec 2022 | $25.60 M(+43.0%) | $25.60 M(+0.3%) |
| Sep 2022 | - | $25.54 M(+2.2%) |
| Jun 2022 | - | $24.99 M(-4.0%) |
| Mar 2022 | - | $26.03 M(+45.4%) |
| Dec 2021 | $17.91 M(-13.2%) | $17.91 M(+16.6%) |
| Sep 2021 | - | $15.36 M(-8.4%) |
| Jun 2021 | - | $16.76 M(-12.0%) |
| Mar 2021 | - | $19.05 M(-7.6%) |
| Dec 2020 | $20.62 M | $20.62 M(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $19.06 M(-10.1%) |
| Jun 2020 | - | $21.20 M(+37.5%) |
| Mar 2020 | - | $15.41 M(-9.4%) |
| Dec 2019 | $17.02 M(+49.4%) | $17.02 M(-6.4%) |
| Sep 2019 | - | $18.19 M(-15.3%) |
| Jun 2019 | - | $21.48 M(+5.0%) |
| Mar 2019 | - | $20.45 M(+79.5%) |
| Dec 2018 | $11.39 M(+113.1%) | $11.39 M(+120.0%) |
| Sep 2018 | - | $5.18 M(+33.4%) |
| Jun 2018 | - | $3.88 M(-4.9%) |
| Mar 2018 | - | $4.08 M(-23.6%) |
| Dec 2017 | $5.35 M(+384.3%) | $5.35 M(+179.2%) |
| Sep 2017 | - | $1.91 M(+21.2%) |
| Jun 2017 | - | $1.58 M(+43.1%) |
| Dec 2016 | $1.10 M(+193.4%) | $1.10 M |
| Dec 2015 | $376.30 K | - |
FAQ
- What is Cue Biopharma annual total liabilities?
- What is the all time high annual total liabilities for Cue Biopharma?
- What is Cue Biopharma annual total liabilities year-on-year change?
- What is Cue Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cue Biopharma?
- What is Cue Biopharma quarterly total liabilities year-on-year change?
What is Cue Biopharma annual total liabilities?
The current annual total liabilities of CUE is $24.45 M
What is the all time high annual total liabilities for Cue Biopharma?
Cue Biopharma all-time high annual total liabilities is $25.60 M
What is Cue Biopharma annual total liabilities year-on-year change?
Over the past year, CUE annual total liabilities has changed by -$1.16 M (-4.52%)
What is Cue Biopharma quarterly total liabilities?
The current quarterly total liabilities of CUE is $19.44 M
What is the all time high quarterly total liabilities for Cue Biopharma?
Cue Biopharma all-time high quarterly total liabilities is $27.16 M
What is Cue Biopharma quarterly total liabilities year-on-year change?
Over the past year, CUE quarterly total liabilities has changed by -$1.26 M (-6.10%)